Search results
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 6 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 2 days agoLast year, Novavax lost $5.41 per share and had $983.7 million in sales. This year, Wall Street...
Novavax’s South African Phase IIb COVID-19 vaccine trial likely to reveal results within next...
Pharmaceutical Technology via Yahoo Finance· 5 days agoSouth Africa’s existing regulatory, consent and ethics frameworks around HIV vaccine trial investigations helped with regards to quick initiation and straightforward progress ...
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 3 days agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman via Yahoo News· 2 days agoThe Centers for Disease Control and Prevention recommends everyone 6 months and older get an updated...
A Synergy Of Excellence: Novavax-Mabion Partnership During Unprecedented Times Amid The Covid-19...
BioresearchOnline· 3 days agoNovavax's COVID-19 vaccine, Nuvaxovid, was developed in record time with the support of Mabion, a...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 5 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Jim Cramer Says He's 'Going To Have To Wait' On SoFi, But Recommends This 'Great Little Industrial...
Benzinga· 6 days agoOn CNBC's “Mad Money Lightning Round,” Jim Cramer said he still can't recommend Twilio TWLO. On June...
Why 93% Of This Biotech's Value Just Went Up In Smoke
Investor's Business Daily· 6 days agoWedbush analyst Laura Chico slashed her price target on Aerovate stock to 3 from 41, calling the...